Bevacizumab and dehydration 
Bevacizumab and dehydration Patient Reports February 10, 2012
Bevacizumab Side Effects Report #5253983-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Feb 28, 2007. Male patient, 76 years of age, weighting 172.0 lb, was diagnosed with tonsil cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, dehydration, vomiting. Bevacizumab dosage: 10 MG/KG Q 2 WEEKS IV. During the same period patient was treated with ERLOTINIB HYDROCHLORIDE, ERLOTINIB HYDROCHLORIDE, CISPLATIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5354555-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 01, 2007. Male patient, weighting 184.0 lb, was diagnosed with squamous cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain
, constipation , dehydration, diverticulitis. Bevacizumab dosage: 15 MG/KG, DAYS 1+22. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, FLUOROURACIL, WELLBUTRIN, DIGITEK, ZOCOR, INSULIN, ACTOS. Patient was hospitalized. Patient died on 05/18/2007.Bevacizumab Side Effects Report #5366991-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 15, 2007. Male patient, weighting 184.0 lb, was diagnosed with squamous cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain
, constipation , dehydration, diverticulitis. Bevacizumab dosage: 15 MG/KG, DAYS 1+22. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, FLUOROURACIL, WELLBUTRIN, DIGITEK, ZOCOR, INSULIN, ACTOS. Patient was hospitalized. Patient died on 05/18/2007.Bevacizumab Side Effects Report #5724017-X
Bevacizumab side effect was reported by a Physician from SPAIN on Apr 16, 2008. Male patient, weighting 114.6 lb, was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, diabetic ketoacidosis, neutropenia. Bevacizumab dosage: 400 MG, Q21D. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, REPAGLINIDE, METFORMINA, INSULIN. Patient died on 04/14/2008.
Bevacizumab Side Effects Report #5729521-6
Bevacizumab side effect was reported by a Physician from SPAIN on Apr 21, 2008. Male patient, weighting 114.6 lb, was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, diabetic ketoacidosis, neutropenia. Bevacizumab dosage: 400 MG, Q21D. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, REPAGLINIDE, METFORMINA, INSULIN. Patient died on 04/14/2008.
Bevacizumab Side Effects Report #5764174-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 26, 2008. Male patient, weighting 114.6 lb, was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, diabetic ketoacidosis, neutropenia. Bevacizumab dosage: 400 MG, Q21D. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, REPAGLINIDE, METFORMINA, INSULIN. Patient died on 04/14/2008.
Bevacizumab Side Effects Report #5224744-7
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on Jan 29, 2007. Male patient, 72 years of age, weighting 186.0 lb, was diagnosed with prostate cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, chills, dehydration, fatigue, mucosal inflammation, myalgia, nausea , pyrexia, unevaluable event. Bevacizumab dosage: 455 MG X1 IV. During the same period patient was treated with DOCETAXEL, CHEMO, LISINOPRIL, POTASSIUM ACETATE, FERROS GLUCONATE, FUROSEMIDE, GLYBURIDE, METOPROLOL TARTRATE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4986493-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Apr 15, 2006. Female patient, 79 years of age, weighting 140.0 lb, was diagnosed with peritoneal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, atelectasis, blood pressure systolic increased, cerebral infarction, cerebral ischaemia, cholelithiasis, dehydration, disorientation. Bevacizumab dosage: 925 MG, Q3W, INTRAVENOUS. During the same period patient was treated with LORTAB, ATIVAN, AMITRIPTYLINE, SUDAFED, FIORICET, PREVACID, ASPIRIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5008454-7
Bevacizumab side effect was reported by a Physician from UNITED STATES on May 22, 2006. Male patient, weighting 250.0 lb, was diagnosed with pancreatic neoplasm and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain upper, chills, dehydration, diarrhoea, fatigue, flatulence, hypoaesthesia, hypotension. Bevacizumab dosage: 570 MG QS Q2 WKS. During the same period patient was treated with DEXAMETHASONE, LORAZEPAM, GRANISETRON, OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL, PROTONIX, SANDOSTATIN LAR. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5410227-8
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 31, 2007. Female patient was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, hypokalaemia, hypomagnesaemia. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with CISPLATIN, TAXOL, ACETAMINOPHEN, AL HYDROXIDE, AMLODIPINE, APREPITANT, ASPIRIN, ATORVASTATIN CALCIUM. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5447680-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 06, 2007. Male patient, 75 years of age, weighting 113.8 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, febrile neutropenia. Bevacizumab dosage: 10MG/KG DAY 1 Q 3 WEEKS IV (C1+C2). During the same period patient was treated with DOCETAXEL, IRINOTECAN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5483688-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Oct 09, 2007. Male patient, 49 years of age, weighting 200.4 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea haemorrhagic, disease progression, dyspnoea, hypotension, small intestinal obstruction, west nile viral infection. Bevacizumab dosage: 10 MG QCD1 IV. During the same period patient was treated with CISPLATIN, DOCETAXEL, IRINOTECAN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5608791-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 29, 2008. Male patient, 49 years of age, weighting 200.4 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, depressed level of consciousness, disease progression, dyspnoea, encephalopathy, hypotension, small intestinal obstruction, virus serology test positive. Bevacizumab dosage: 10 MG QCD1 AND8 IV. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5027164-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 01, 2006. Male patient, 39 years of age, weighting 242.5 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, dehydration, dysphagia, vomiting. Bevacizumab dosage: 5 MG/KG, DAYS 1 + 15, INTRAVENOUS. During the same period patient was treated with DOCETAXEL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5386875-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 05, 2007. Female patient, weighting 94.98 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, hypomagnesaemia, hypophosphataemia, vomiting. Bevacizumab dosage: 10 MG/M2, UNK. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN, ATENOLOL, COMPAZINE, FENTANYL TRANSDERMAL SYSTEM, MAALOX FAST BLOCKER, TYLENOL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5391553-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on July 12, 2007. Female patient, weighting 94.98 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: candidiasis, dehydration, diarrhoea, hypomagnesaemia, hypophosphataemia, vomiting. Bevacizumab dosage: 10 MG/M2, UNK. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN, ATENOLOL, COMPAZINE, FENTANYL, MAALOX FAST BLOCKER, TYLENOL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5595193-7
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 10, 2008. Male patient, weighting 156.5 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain upper, atrial fibrillation
, dehydration, sepsis . Bevacizumab dosage: 15 MG/KG, DAYS 1+22. During the same period patient was treated with ERLOTINIB, FLUOROURACIL, CARBOPLATIN, PACLITAXEL, OXYCODONE, VALIUM. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5601543-5
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 17, 2008. Male patient, weighting 156.5 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain upper, atrial fibrillation
, dehydration, sepsis . Bevacizumab dosage: 15 MG/KG, DAYS 1+22. During the same period patient was treated with ERLOTINIB, FLUOROURACIL, CARBOPLATIN, PACLITAXEL, PROTONIX, LORTAB, OXYCODONE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5783012-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 18, 2008. Female patient, weighting 71.99 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, failure to thrive, oesophagitis. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with ERLOTINIB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5800882-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 27, 2008. Female patient, weighting 71.99 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, failure to thrive, oesophagitis. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with ERLOTINIB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5812202-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 11, 2008. Female patient, weighting 71.99 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, failure to thrive, oesophagitis. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with ERLOTINIB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5815513-5
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 15, 2008. Male patient, weighting 139.0 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, mucosal inflammation, oesophagitis. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with ERLOTINIB, TAXOL, CARBOPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5868961-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 02, 2008. Male patient, weighting 145.0 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anorexia, atrial flutter, dehydration, fatigue, sinus tachycardia, weight decreased. Bevacizumab dosage: 987 MG IV. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5719812-7
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on Apr 23, 2008. Male patient was diagnosed with oesophageal adenocarcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anorexia, dehydration, odynophagia, oesophagitis. Bevacizumab dosage: unknown. During the same period patient was treated with CISPLATIN, IRINOTECAN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5745905-4
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on May 13, 2008. Male patient was diagnosed with oesophageal adenocarcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis
, dehydration, hypocalcaemia, hypokalaemia, hypomagnesaemia, neutropenia, nodule, oesophageal ulcer, oesophagitis. Bevacizumab dosage: unknown. During the same period patient was treated with CISPLATIN, IRINOTECAN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5416836-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Aug 15, 2007. Male patient, 81 years of age, weighting 143.3 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anorexia, asthenia, dehydration, fatigue, hypernatraemia, hypokalaemia, oral intake reduced, weight decreased. Bevacizumab dosage: 1050 MG Q21 DAYS IV. During the same period patient was treated with PEMETREXED, ERLOTINIB, PROSCAR, INDAPAMIDE, LISINOPRIL, TERAZOSIN, LIPITOR, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5301453-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Apr 12, 2007. Male patient, 59 years of age, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, oesophageal pain, performance status decreased. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5060022-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 11, 2006. Female patient, 49 years of age, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, nausea
. Bevacizumab dosage: 10 MG/KG. During the same period patient was treated with TAXOL, CARBOPLATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5041299-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 16, 2006. Female patient, 49 years of age, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, nausea
. Bevacizumab dosage: 10 MG/KG,. During the same period patient was treated with TAXOL, CARBOPLATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5363507-9
Bevacizumab side effect was reported by a Physician from UNITED STATES on June 12, 2007. Female patient, weighting 134.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, sepsis
. Bevacizumab dosage: 913 MG, Q3W. During the same period patient was treated with CARBOPLATIN, TAXOL. Patient died on 06/10/2007.Bevacizumab Side Effects Report #5387633-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 06, 2007. Female patient, weighting 150.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, asthenia, dehydration, dizziness
, hypokalaemia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with ALIMTA, CARBOPLATIN, RADIATION. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5392590-X
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 12, 2007. Female patient, weighting 134.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, sepsis
. Bevacizumab dosage: 913 MG, Q3W. During the same period patient was treated with CARBOPLATIN, TAXOL. Patient died on 06/10/2007.Bevacizumab Side Effects Report #5395518-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 19, 2007. Female patient, weighting 150.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, asthenia, dehydration, dizziness
, hypokalaemia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with ALIMTA, CARBOPLATIN, RADIATION, FOLIC ACID. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5419471-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 14, 2007. Male patient, weighting 142.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anorexia, dehydration, fatigue, hypernatraemia, hypokalaemia, weight decreased. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with ERLOTINIB, PEMETREXED, PROSCAR, INDAPAMIDE, LISINOPRIL, TERAZOSIN, LIPITOR, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5444002-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 29, 2007. Male patient, weighting 142.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anorexia, dehydration, fatigue, hypernatraemia, hypokalaemia, weight decreased. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with ERLOTINIB, PEMETREXED, PROSCAR, INDAPAMIDE, LISINOPRIL, TERAZOSIN, LIPITOR, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5487182-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 03, 2007. Female patient, weighting 101.4 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, dehydration. Bevacizumab dosage: 634 MG, Q3W. During the same period patient was treated with ENALAPRIL MALEATE, CLONIDINE, BROMAZEPAM, VERAPAMIL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5718497-3
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 10, 2008. Male patient, weighting 180.3 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aplasia pure red cell, dehydration, diarrhoea. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, BENIDIPINE, LOSARTAN POTASSIUM, AMLODIPINE BESYLATE. Patient recovered.
Bevacizumab Side Effects Report #5722453-9
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 14, 2008. Female patient, weighting 129.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration. Bevacizumab dosage: 7.5 MG/KG, Q3W. During the same period patient was treated with CISPLATIN, GEMCITABINE, OMEPRAZOLE, SERETIDE, CLOBAZAM, ACETYLCYSTEINE, AMINOPYRINE, NYLIDRIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5754298-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 16, 2008. Female patient, weighting 101.4 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, haemoglobin decreased. Bevacizumab dosage: 634 MG, Q3W. During the same period patient was treated with ENALAPRIL MALEATE, CLONIDINE, BROMAZEPAM, VERAPAMIL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5759299-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 16, 2008. Female patient, weighting 101.4 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: acute respiratory failure, dehydration, haemoglobin decreased. Bevacizumab dosage: 634 MG, Q3W. During the same period patient was treated with ENALAPRIL MALEATE, CLONIDINE, BROMAZEPAM, VERAPAMIL, CEFTRIAXONE, HYDROCORTISONE. Patient was hospitalized. Patient died on 10/05/2007.
Bevacizumab Side Effects Report #5760106-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on May 22, 2008. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state, dehydration, hypotension. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with GLYBURIDE, METFORMIN, DIAZEPAM, LIPITOR, DILAUDID, MONOCOR, HYSRON. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5875646-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 25, 2008. Female patient, weighting 101.4 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, dehydration, haemoglobin decreased. Bevacizumab dosage: 634 MG, Q3W. During the same period patient was treated with ENALAPRIL MALEATE, CLONIDINE, BROMAZEPAM, VERAPAMIL, CEFTRIAXONE, HYDROCORTISONE. Patient was hospitalized. Patient died on 10/05/2007.
Bevacizumab Side Effects Report #5929928-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 10, 2008. Female patient, weighting 101.4 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, dehydration, haemoglobin decreased, hypoproteinaemia, pneumonia
. Bevacizumab dosage: 634 MG, Q3W. During the same period patient was treated with ENALAPRIL MALEATE, CLONIDINE, BROMAZEPAM, VERAPAMIL, CEFTRIAXONE, HYDROCORTISONE. Patient was hospitalized. Patient died on 10/05/2007.Bevacizumab Side Effects Report #5944151-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 10, 2008. Female patient, weighting 101.4 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, dehydration, haemoglobin decreased, hypoproteinaemia, pneumonia
. Bevacizumab dosage: 634 MG, Q3W. During the same period patient was treated with ENALAPRIL MALEATE, CLONIDINE, BROMAZEPAM, VERAPAMIL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6038013-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 14, 2009. Male patient, weighting 193.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: constipation
, dehydration, nausea , obstruction. Bevacizumab dosage: 10 MG/KG - IV Q2WEEKS 1 TREATMENT. During the same period patient was treated with GEMCITABINE, PACLITAXEL, ASPIRIN, COMBIVANT, LIPITOR, ZEMBETA, ZYRTEC, ZOFRAN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6072691-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on Feb 02, 2009. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, haemoglobin decreased, thrombosis, vomiting. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with GEMCITABINE, CISPLATIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #6086396-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Feb 12, 2009. Male patient, weighting 193.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, haematocrit decreased, intestinal obstruction, intestinal perforation, platelet count increased, pneumoperitoneum, sepsis
. Bevacizumab dosage: 875 MG, UNK. During the same period patient was treated with GEMCITABINE, PACLITAXEL, ASPIRIN, COMBIVENT, LIPITOR, ZEBETA, ZYRTEC, ZOFRAN. Patient was hospitalized. Patient died on 02/08/2009.Bevacizumab Side Effects Report #4558865-9
Bevacizumab side effect was reported by a Consumer or non-health professional from on Jan 21, 2005. Male patient, weighting 132.3 lb, was diagnosed with neuroendocrine tumour and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, blood creatine phosphokinase increased, dehydration, fall
, hypoglycaemia, liver function test abnormal, pollakiuria, troponin increased. Bevacizumab dosage: 5 MG/KG D 1 + 15 INTRAVENOU. During the same period patient was treated with TEMOZOLOMIDE, ATIVAN, COMPAZINE, CREON, DOXAZOSIN, LASIX, LISINOPRIL. Patient died on 12/26/2004.Bevacizumab Side Effects Report #5969358-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 20, 2008. Female patient was diagnosed with neuroendocrine carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, gastroenteritis
. Bevacizumab dosage: 15 MG/KG, Q21D. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6014937-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 12, 2008. Male patient, weighting 147.7 lb, was diagnosed with neuroendocrine carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, hypokalaemia, orthostatic hypotension. Bevacizumab dosage: 7.5 MG/KG, UNK. During the same period patient was treated with XELODA, HYTRIN, AVODART, PRILOSEC, MARINOL, CELEXA. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #6127181-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 12, 2009. Male patient, weighting 147.7 lb, was diagnosed with neuroendocrine carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, hypokalaemia, orthostatic hypotension. Bevacizumab dosage: 7.5 MG/KG, UNK. During the same period patient was treated with XELODA, HYTRIN, AVODART, PRILOSEC, MARINOL, CELEXA. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5143840-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 01, 2006. Male patient, 56 years of age, weighting 154.3 lb, was diagnosed with neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aspiration, dehydration, hiccups, nausea
, pneumonia . Bevacizumab dosage: 812MG WKS 1,3,5 DELAYED. During the same period patient was treated with CISPLATIN, ERLOTINIB, ZOFRAN, DULCOLAX, DECADRON. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5384847-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 03, 2007. Male patient, 72 years of age, was diagnosed with metastatic gastric cancer, insomnia and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, hypokalaemia, wound infection. Bevacizumab dosage: 10 MG/KG, UNK. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN, NEXIUM, NORVASC, ATIVAN, DECADRON, ZOFRAN. Patient recovered.
Bevacizumab Side Effects Report #5977621-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 01, 2008. Male patient, 71 years of age, weighting 172.4 lb, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anorexia, blood pressure orthostatic, dehydration, fluid intake reduced, hypophagia, nausea
, neutropenia. Bevacizumab dosage: 7.5 MG/KG D1/22DAYCYCLE. During the same period patient was treated with OXALIPLATIN, DOCETAXEL, DECADRON, OMEPRAZOLE, RESTORIL, ZOFRAN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4887657-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 19, 2006. Female patient, 71 years of age, weighting 126.1 lb, was diagnosed with mesothelioma
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, chest pain , dehydration, gastrointestinal haemorrhage, haemoglobin decreased, oedema peripheral, thrombosis. Bevacizumab dosage: 858 MG ., QD/DAYS IV. During the same period patient was treated with TARCEVA. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5004212-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on May 03, 2006. Male patient, 67 years of age, weighting 250.0 lb, was diagnosed with insulinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, chills, dehydration, vomiting. Bevacizumab dosage: 570 MG, Q2W, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, PROTONIX, SANDOSTATIN, LORAZEPAM, GRANISETRON, OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5021746-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on May 22, 2006. Male patient, 67 years of age, weighting 250.0 lb, was diagnosed with insulinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, chills, dehydration, diarrhoea, fatigue, vomiting. Bevacizumab dosage: 570 MG, Q2W, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, LORAZEPAM, GRANISETRON, OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, PROTONIX, SANDOSTATIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5330816-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on May 18, 2007. Male patient, 81 years of age, weighting 181.0 lb, was diagnosed with hepatic neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anorexia, chills, dehydration, diarrhoea, diverticulitis, hepatic mass, infection
, oral intake reduced. Bevacizumab dosage: 1567 MG IV Q 21 DAYS. During the same period patient was treated with ERLOTINIB, ASPIRIN, TOPROL, CLONIDINE, COZAAR, NORVASC, UNIRETIC, METFORMIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5897910-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 24, 2008. Male patient, 65 years of age, weighting 153.0 lb, was diagnosed with head and neck cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, blood culture positive, constipation , dehydration, faecal incontinence, hypotension, lethargy, pneumonia aspiration. Bevacizumab dosage: 337 MG QOWK X 4. During the same period patient was treated with TAXOTERE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5922917-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Oct 09, 2008. Female patient, weighting 107.0 lb, was diagnosed with head and neck cancer
, squamous cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, weight decreased. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with PEMETREXED, OXYCODONE, FOLIC ACID, DEXAMETHASONE, OXYCONTIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5677809-X
Bevacizumab side effect was reported by a Physician from UNITED STATES on Mar 17, 2008. Female patient, 53 years of age, was diagnosed with glioma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: acute prerenal failure, anorexia, blood amylase increased, blood creatinine increased, dehydration, depression
, gastroenteritis viral, hypotension, infection . Bevacizumab dosage: unknown. During the same period patient was treated with ENZASTAURIN, DEXAMETHASONE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5668725-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 12, 2008. Female patient, 67 years of age, weighting 180.8 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal distension, chest pain
, dehydration, nausea . Bevacizumab dosage: 10 MG/KG, IV Q2WKS. During the same period patient was treated with TEMOZOLOMIDE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5290488-9
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 05, 2007. Male patient was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, fall
, hyponatraemia, nausea . Bevacizumab dosage: 10 MG/KG. During the same period patient was treated with ERLOTINIB, TOPROL, PREVACID, RITALIN, KEPPRA, DECADRON, LOVASTATIN, COLACE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5297826-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 16, 2007. Male patient was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, disease progression, fall
, hyponatraemia, nausea , pneumonia , somnolence. Bevacizumab dosage: 10 MG/KG. During the same period patient was treated with ERLOTINIB, TOPROL, PREVACID, RITALIN, KEPPRA, DECADRON, LOVASTATIN, COLACE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5301842-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 16, 2007. Male patient was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, fall
, hyponatraemia, malignant neoplasm progression, nausea , nuclear magnetic resonance imaging brain abnormal, pneumonia , somnolence. Bevacizumab dosage: 10 MG/KG. During the same period patient was treated with ERLOTINIB, TOPROL, PREVACID, RITALIN, KEPPRA, DECADRON, LOVASTATIN, COLACE. Patient was hospitalized. Patient died on 04/13/2007.Bevacizumab Side Effects Report #5563578-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 14, 2007. Male patient, weighting 141.1 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, renal failure acute, urine output decreased. Bevacizumab dosage: 10MG/KG IV Q 2 WEEKS. During the same period patient was treated with TEMOZOLOMIDE, LEXAPRO, KEPPRA, DEPAKOTE ER, LORAZEPAM, GABAPENTIN, DECADRON, PRILOSEC. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5564290-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 14, 2007. Male patient, weighting 141.1 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, renal failure acute. Bevacizumab dosage: 10MG/KG IV Q 2 WEEKS. During the same period patient was treated with TEMOZOLOMIDE, LEXAPRO, DECADRON, KEPPRA, PRILOSEC, DEPAKOTE ER, LORAZEPAM, GABAPENTIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5745825-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on May 07, 2008. Male patient was diagnosed with glioblastoma multiforme, brain oedema and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, hyperglycaemia. Bevacizumab dosage: 10 MG/KG, UNK. During the same period patient was treated with CETUXIMAB, IRINOTECAN, PREDNISOLONE, EFFEXOR, DEPRAKINE, METOCLOPRAMIDE, PAMOL, SERENASE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5232175-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 22, 2007. Female patient, 59 years of age, weighting 219.8 lb, was diagnosed with glioblastoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: caecitis, cerebral haemorrhage, chest pain
, dehydration, disease progression, mental status changes, neutropenia, red blood cell count decreased, thrombocytopenia. Bevacizumab dosage: 997 MG, Q2W, INTRAVENOUS. During the same period patient was treated with IRINOTECAN, CEFTAZIDIME, NEUPOGEN, DEXAMETHASONE, OXYGEN, RANITIDINE, FUROSEMIDE, OCTREOTIDE ACETATE. Patient was hospitalized and became disabled. Patient died.Bevacizumab Side Effects Report #5144360-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Oct 17, 2006. Female patient, 59 years of age, weighting 219.8 lb, was diagnosed with glioblastoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: caecitis, cerebral haemorrhage, chest pain
, dehydration, haematocrit decreased, mental status changes, neutropenia, red blood cell count decreased, somnolence. Bevacizumab dosage: 997 MG, Q2W, INTRAVENOUS. During the same period patient was treated with IRINOTECAN, CEFTAZIDIME, NEUPOGEN, DEXAMETHASONE, OXYGEN, RANITIDINE, FUROSEMIDE, OCTREOTIDE ACETATE. Patient was hospitalized and became disabled. Patient recovered.Bevacizumab Side Effects Report #5155827-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 03, 2006. Female patient, 59 years of age, weighting 219.8 lb, was diagnosed with glioblastoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: caecitis, cerebral haemorrhage, chest pain
, dehydration, haematocrit decreased, mental status changes, neutropenia, red blood cell count decreased, thrombocytopenia. Bevacizumab dosage: 997 MG, Q2W, INTRAVENOUS. During the same period patient was treated with IRINOTECAN, CEFTAZIDIME, NEUPOGEN, DEXAMETHASONE, OXYGEN, RANITIDINE, FUROSEMIDE, OCTREOTIDE ACETATE. Patient was hospitalized and became disabled. Patient died.Bevacizumab Side Effects Report #5752668-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on May 27, 2008. Male patient, 57 years of age, weighting 166.7 lb, was diagnosed with gastrointestinal disorder and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, febrile neutropenia. Bevacizumab dosage: unknown. During the same period patient was treated with DOCETAXEL, OXALIPLATIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5007331-5
Bevacizumab side effect was reported by a Physician from UNITED STATES on May 18, 2006. Female patient, weighting 169.1 lb, was diagnosed with endocrine pancreatic disorder, neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, aortic disorder, blood pressure diastolic decreased, chest pain , condition aggravated, dehydration, haematoma, hypertension, jejunal ulcer. Bevacizumab dosage: 37.5 MG QS, Q 2 WEEKS, IV. During the same period patient was treated with DEXAMETHASONE, ALOXI, OXALIPLATIN, LEUCOVORIN CALCIUM. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5300938-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 17, 2007. Female patient, weighting 114.2 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, pyrexia. Bevacizumab dosage: 400 MG, Q3W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, MOTILIUM, ZOTON, BETALOC, CENTYL K. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5448034-2
Bevacizumab side effect was reported by a Physician from AUSTRALIA on Aug 22, 2007. Female patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, renal failure acute. Bevacizumab dosage: 7.5 MG, Q3W. During the same period patient was treated with CAPECITABINE, MITOMYCIN, GASTRO, METOCLOPRAMIDE, SYNACTHEN, CHLORVESCENT. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5454064-7
Bevacizumab side effect was reported by a Physician from AUSTRALIA on Sept 03, 2007. Female patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, renal failure acute. Bevacizumab dosage: 7.5 MG, Q3W. During the same period patient was treated with CAPECITABINE, MITOMYCIN, GASTRO, METOCLOPRAMIDE, SYNACTHEN, CHLORVESCENT. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5463494-9
Bevacizumab side effect was reported by a Physician from AUSTRALIA on Sept 06, 2007. Female patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, renal failure acute. Bevacizumab dosage: 7.5 MG, Q3W. During the same period patient was treated with CAPECITABINE, MITOMYCIN, GASTRO, METOCLOPRAMIDE, SYNACTHEN, CHLORVESCENT. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5478664-3
Bevacizumab side effect was reported by a Consumer or non-health professional from SWITZERLAND on Sept 20, 2007. Male patient, weighting 209.9 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, hypertension, lethargy, pyrexia. Bevacizumab dosage: 475 MG, Q2W. During the same period patient was treated with FLUOROURACIL, FOLINIC ACID, ONDANSETRON. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5603086-1
Bevacizumab side effect was reported by a Physician from AUSTRALIA on Jan 16, 2008. Female patient, weighting 101.4 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, renal failure acute. Bevacizumab dosage: 7.5 MG, Q3W. During the same period patient was treated with CAPECITABINE, MITOMYCIN, GASTRO, METOCLOPRAMIDE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5663474-4
Bevacizumab side effect was reported by a Physician from AUSTRALIA on Mar 04, 2008. Female patient, weighting 101.4 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, renal failure acute. Bevacizumab dosage: 7.5 MG, Q3W. During the same period patient was treated with CAPECITABINE, MITOMYCIN, GASTRO, METOCLOPRAMIDE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5718547-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Apr 14, 2008. Female patient, weighting 144.0 lb, was diagnosed with colorectal cancer metastatic, deep vein thrombosis
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood potassium decreased, blood sodium decreased, dehydration, gastric cancer, malnutrition, white blood cell count decreased. Bevacizumab dosage: 350 MG, Q2W. During the same period patient was treated with CETUXIMAB, FLUOROURACIL, LEUCOVORIN CALCIUM, COUMADIN, BENADRYL, TYLENOL, DECADRON. Patient recovered.Bevacizumab Side Effects Report #5912610-0
Bevacizumab side effect was reported by a Physician from UNITED STATES on Oct 01, 2008. Male patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, electrolyte imbalance, metabolic acidosis, mucosal inflammation, oxygen saturation decreased, paraneoplastic syndrome, respiratory acidosis, respiratory alkalosis, sepsis
. Bevacizumab dosage: 385.5 MG, Q2W. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL, COUMADIN, COZAAR, CARDIZEM, PEPCID. Patient was hospitalized. Patient died on 07/31/2007.Bevacizumab Side Effects Report #5957424-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 06, 2008. Female patient, weighting 132.3 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anorexia, blood bilirubin increased, creatinine renal clearance decreased, dehydration, diarrhoea, fatigue, nausea
, platelet count increased. Bevacizumab dosage: 450 MG, Q3W. During the same period patient was treated with CAPECITABINE, ASPIRIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5979346-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 20, 2008. Female patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, depression
, irritable bowel syndrome . Bevacizumab dosage: 500 MG, Q3W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, CYMBALTA, PROZAC, COUMADIN, NEXIUM, RITALIN. Patient recovered.Bevacizumab Side Effects Report #6019794-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 09, 2008. Female patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, depression
, irritable bowel syndrome . Bevacizumab dosage: 500 MG, Q3W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, CYMBALTA, PROZAC, COUMADIN, NEXIUM, RITALIN. Patient recovered.Bevacizumab Side Effects Report #6052302-3
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Jan 13, 2009. Female patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, depression
, irritable bowel syndrome . Bevacizumab dosage: 500 MG, Q3W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, CYMBALTA, PROZAC, COUMADIN, RITALIN, NEXIUM, MAGNESIUM OXIDE. Patient recovered.Bevacizumab Side Effects Report #6085733-6
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Feb 05, 2009. Male patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, sepsis
. Bevacizumab dosage: unknown. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, BETAMETHASONE, PALONOSETRON, MAGNESIUM SULPHATE, CALCIUM GLUCONATE. Patient was hospitalized. Patient died on 08/18/2008.Bevacizumab Side Effects Report #5007480-1
Bevacizumab side effect was reported by a Physician from UNITED STATES on May 15, 2006. Female patient, 81 years of age, weighting 129.0 lb, was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: acute prerenal failure, blood calcium decreased, blood potassium decreased, dehydration, diarrhoea, electrolyte imbalance, fatigue, hyperglycaemia, hypotension. Bevacizumab dosage: 10 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, CLARITIN, VITAMIN, IRON. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4668433-6
Bevacizumab side effect was reported by a Physician from on May 09, 2005. Female patient, 36 years of age, was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal mass, abdominal pain , anorexia, back pain , colorectal cancer metastatic, deep vein thrombosis , dehydration, dizziness . Bevacizumab dosage: 5 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with CETUXIMAB. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4687994-4
Bevacizumab side effect was reported by a Consumer or non-health professional from on May 24, 2005. Female patient, 36 years of age, was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal mass, atelectasis, back pain , bacteria blood identified, deep vein thrombosis , dehydration, dizziness , gastric outlet obstruction. Bevacizumab dosage: 5 MG/KG, Q2WL INTRAVENOUS (SEE IMAGE). During the same period patient was treated with CETUXIMAB. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5322518-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 26, 2007. Male patient was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, fistula , hypokalaemia. Bevacizumab dosage: 525 MG, Q3W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, LOPERAMIDE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5586782-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 27, 2007. Male patient was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, pain , pyrexia. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, COZAAR, METFORMIN, ATENOLOL, CIPRO, LOVASTATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5660915-3
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Feb 27, 2008. Male patient was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, pain , pyrexia. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, COZAAR, METFORMIN, ATENOLOL, CIPRO, LOVASTATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5726476-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 18, 2008. Male patient was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: bacterial sepsis, dehydration, oesophagitis. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, ONDANSETRON, CIPRO, NYSTATIN, OPIUM, TRAZODONE, COZAAR. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5779708-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on June 05, 2008. Male patient was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: bacterial sepsis, dehydration, oesophagitis. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, ONDANSETRON, CIPRO, NYSTATIN, OPIUM, TRAZODONE, COZAAR. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5837775-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 24, 2008. Female patient was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , dehydration, pyrexia. Bevacizumab dosage: 400 MG, QD. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, CETUXIMAB, METOCLOPRAMIDE, LOPERAMIDE, NEXIUM. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5915942-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Sept 25, 2008. Male patient was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: bacterial sepsis, dehydration, oesophagitis. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, ONDANSETRON, CIPRO, NYSTATIN, OPIUM. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5921262-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 01, 2008. Male patient was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: bacteraemia, dehydration, oesophagitis. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, ONDANSETRON, CIPRO, NYSTATIN, OPIUM. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5926996-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 10, 2008. Female patient was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, hypovolaemic shock. Bevacizumab dosage: 7.5 MG/KG, UNK. During the same period patient was treated with CETUXIMAB, OXALIPLATIN, IRINOTECAN HYDROCHLORIDE, FLUOROURACIL, LEUCOVORIN CALCIUM. Patient recovered.Bevacizumab Side Effects Report #5958774-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 04, 2008. Female patient was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, hypotension, pyrexia. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5965105-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 12, 2008. Female patient was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, hypovolaemic shock, pulmonary embolism . Bevacizumab dosage: 7.5 MG/KG, ^2 IN 5 WK^. During the same period patient was treated with CETUXIMAB, OXALIPLATIN, IRINOTECAN HYDROCHLORIDE, FLUOROURACIL, LEUCOVORIN CALCIUM. Patient recovered.Bevacizumab Side Effects Report #5966855-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 12, 2008. Male patient was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood creatinine increased, dehydration, diarrhoea, hypokalaemia, renal failure. Bevacizumab dosage: 7.5 MG/KG, UNK. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, CETUXIMAB, IRINOTECAN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6092823-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 10, 2009. Male patient was diagnosed with colorectal cancer
, colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, renal failure. Bevacizumab dosage: 435 MG, Q2W. During the same period patient was treated with FLUOROURACIL, TRIATEC, FLUDEX, DIAMICRON. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6131879-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 11, 2009. Male patient was diagnosed with colorectal cancer
, colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, renal failure. Bevacizumab dosage: 435 MG, Q2W. During the same period patient was treated with FLUOROURACIL, TRIATEC, FLUDEX, DIAMICRON. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4990612-9
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on May 01, 2006. Male patient, weighting 160.3 lb, was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: colitis, dehydration, diarrhoea, neutrophil count decreased, white blood cell count decreased. Bevacizumab dosage: 364 MG. During the same period patient was treated with CAMPTOSAR. Patient was hospitalized. Patient recovered.